Unbound MEDLINE

Herpes simplex type-2 meningitis: presentation and lack of standardized therapy. The American journal of medicine [Am J Med] Journal article

 
TitleHerpes simplex type-2 meningitis: presentation and lack of standardized therapy.
Author(s)Landry ML, Greenwold J, Vikram HR 
InstitutionDepartment of Laboratory Medicine, Yale University School of Medicine, New Haven, CT 06520-8035, USA. marie.landry@yale.edu
SourceAm J Med 2009 Jul; 122(7):688-91.
MeSHAdolescent
Adult
Aged
Aged, 80 and over
Female
Herpes Simplex
Herpesvirus 2, Human
Humans
Male
Meningitis, Aseptic
Middle Aged
Retrospective Studies
Young Adult
AbstractBACKGROUND: Herpes simplex type-2 (HSV-2) causes both primary and recurrent lymphocytic meningitis, but optimal patient management is not well defined.
METHODS: In this retrospective observational study, we reviewed the medical records of patients with HSV-2-positive cerebrospinal fluid samples in our laboratory between January 2001 and January 2005.
RESULTS: During the study period, 23 patients, aged 16 to 83 years, had HSV-2 detected in spinal fluid. Nineteen (83%) had meningitis and 4 (17%) had evidence of meningoencephalitis. Seventy-four percent were female. Two (8.7%) had a history of prior genital herpes, and one (4.3%) had genital lesions noted at the time of presentation. Genital examinations were performed at presentation in only 3 patients. Seven (30.4%) patients reported previous episodes of meningitis. Two celibate women developed HSV-2 meningitis or meningoencephalitis following lumbar steroid injection for spinal stenosis. One woman developed HSV-2 meningoencephalitis 3 days postpartum following cesarean section. Antiviral treatment for uncomplicated HSV-2 meningitis varied from none (4 patients) to 14-21 days of intravenous (IV) acyclovir therapy (4 patients). The 11 remaining patients with meningitis received 1-7 days of IV therapy, followed by 7-21 days of oral antiviral therapy. Three of 4 patients with meningoencephalitis received 21 days of IV acyclovir, and one received 3 days IV acyclovir followed by 14 days of oral therapy.
CONCLUSIONS: HSV-2 meningitis presents most often without a history of genital herpes, recurrent meningitis, or genital symptoms. Current management practices are highly variable and may lead to unnecessary hospitalization and prolonged intravenous therapy.
Languageeng
Pub Type(s)Journal Article
PubMed ID19559173
  
Advertise on this site.